Alterity Therapeutics Ltd (ATH)

0.016
0.000(0.00%)
  • Volume:
    700,373
  • Bid/Ask:
    0.015/0.016
  • Day's Range:
    0.015 - 0.016
Earnings results expected in 11 days

ATH Overview

Prev. Close
0.016
Day's Range
0.015-0.016
Revenue
10K
Open
0.015
52 wk Range
0.013-0.034
EPS
-0.01
Volume
700,373
Market Cap
38.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,831,289
P/E Ratio
-
Beta
0.68
1-Year Change
-50%
Shares Outstanding
2,406,874,578
Next Earnings Date
Aug 30, 2022
What is your sentiment on Alterity Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Alterity Therapeutics Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Alterity Therapeutics Ltd Company Profile

Alterity Therapeutics Ltd Company Profile

Employees
0
Market
Australia

Alterity Therapeutics Limited is an Australia-based biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead product candidate, ATH434, is being used for the treatment of various Parkinson's disease, Dementia with lewy bodies (DLB) as well as various forms of atypical Parkinsonism, such as Multiple System Atrophy (MSA). ATH434, is a set of molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The Company also has a drug discovery platform generating chemical to intercede in disease processes. ATH434 has been granted Orphan Drug designation for the treatment of Multiple System Atrophy.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyBuyStrong BuyNeutralStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell